Global Insulin Syringes Market Research Report 2023

Publisher Name :
Date: 27-Jan-2023
No. of pages: 99
Inquire Before Buying

An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.

Highlights

The global Insulin Syringes market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major factors that fuel the growth of the market are the rising aging population and increasing number of diabetic patients globally. In addition, increasing incidence of obesity and people adopting an unhealthy lifestyle supplement the market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Syringes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Syringes.

The Insulin Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Insulin Syringes market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin Syringes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Novo Nordisk

- Sanofi

- Eli Lilly and Company

- Biocon Ltd

- Ypsomed AG

- Wockhardt Ltd

- Medtronic Plc

- Abbott Laboratories

- Animas Corporation

- F. Hoffmann-La Roche

- BD

Segment by Type

- 3/10 CC Syringe

- 1/2 CC Syringe

- 1 CC Syringe

- Others

Segment by Application

- Hospital

- Homecare

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Insulin Syringes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Insulin Syringes Market Research Report 2023

Table of Contents
1 Insulin Syringes Market Overview
1.1 Product Overview and Scope of Insulin Syringes
1.2 Insulin Syringes Segment by Type
1.2.1 Global Insulin Syringes Market Value Comparison by Type (2023-2029)
1.2.2 3/10 CC Syringe
1.2.3 1/2 CC Syringe
1.2.4 1 CC Syringe
1.2.5 Others
1.3 Insulin Syringes Segment by Application
1.3.1 Global Insulin Syringes Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Others
1.4 Global Insulin Syringes Market Size Estimates and Forecasts
1.4.1 Global Insulin Syringes Revenue 2018-2029
1.4.2 Global Insulin Syringes Sales 2018-2029
1.4.3 Global Insulin Syringes Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Insulin Syringes Market Competition by Manufacturers
2.1 Global Insulin Syringes Sales Market Share by Manufacturers (2018-2023)
2.2 Global Insulin Syringes Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Insulin Syringes Average Price by Manufacturers (2018-2023)
2.4 Global Insulin Syringes Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Insulin Syringes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Syringes, Product Type & Application
2.7 Insulin Syringes Market Competitive Situation and Trends
2.7.1 Insulin Syringes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Syringes Players Market Share by Revenue
2.7.3 Global Insulin Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Syringes Retrospective Market Scenario by Region
3.1 Global Insulin Syringes Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Insulin Syringes Global Insulin Syringes Sales by Region: 2018-2029
3.2.1 Global Insulin Syringes Sales by Region: 2018-2023
3.2.2 Global Insulin Syringes Sales by Region: 2024-2029
3.3 Global Insulin Syringes Global Insulin Syringes Revenue by Region: 2018-2029
3.3.1 Global Insulin Syringes Revenue by Region: 2018-2023
3.3.2 Global Insulin Syringes Revenue by Region: 2024-2029
3.4 North America Insulin Syringes Market Facts & Figures by Country
3.4.1 North America Insulin Syringes Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Insulin Syringes Sales by Country (2018-2029)
3.4.3 North America Insulin Syringes Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Syringes Market Facts & Figures by Country
3.5.1 Europe Insulin Syringes Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Insulin Syringes Sales by Country (2018-2029)
3.5.3 Europe Insulin Syringes Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Syringes Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Syringes Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Insulin Syringes Sales by Country (2018-2029)
3.6.3 Asia Pacific Insulin Syringes Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Syringes Market Facts & Figures by Country
3.7.1 Latin America Insulin Syringes Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Insulin Syringes Sales by Country (2018-2029)
3.7.3 Latin America Insulin Syringes Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Syringes Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Syringes Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Insulin Syringes Sales by Country (2018-2029)
3.8.3 Middle East and Africa Insulin Syringes Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Syringes Sales by Type (2018-2029)
4.1.1 Global Insulin Syringes Sales by Type (2018-2023)
4.1.2 Global Insulin Syringes Sales by Type (2024-2029)
4.1.3 Global Insulin Syringes Sales Market Share by Type (2018-2029)
4.2 Global Insulin Syringes Revenue by Type (2018-2029)
4.2.1 Global Insulin Syringes Revenue by Type (2018-2023)
4.2.2 Global Insulin Syringes Revenue by Type (2024-2029)
4.2.3 Global Insulin Syringes Revenue Market Share by Type (2018-2029)
4.3 Global Insulin Syringes Price by Type (2018-2029)
5 Segment by Application
5.1 Global Insulin Syringes Sales by Application (2018-2029)
5.1.1 Global Insulin Syringes Sales by Application (2018-2023)
5.1.2 Global Insulin Syringes Sales by Application (2024-2029)
5.1.3 Global Insulin Syringes Sales Market Share by Application (2018-2029)
5.2 Global Insulin Syringes Revenue by Application (2018-2029)
5.2.1 Global Insulin Syringes Revenue by Application (2018-2023)
5.2.2 Global Insulin Syringes Revenue by Application (2024-2029)
5.2.3 Global Insulin Syringes Revenue Market Share by Application (2018-2029)
5.3 Global Insulin Syringes Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk Insulin Syringes Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Insulin Syringes Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Corporation Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly and Company Insulin Syringes Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Biocon Ltd
6.4.1 Biocon Ltd Corporation Information
6.4.2 Biocon Ltd Description and Business Overview
6.4.3 Biocon Ltd Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocon Ltd Insulin Syringes Product Portfolio
6.4.5 Biocon Ltd Recent Developments/Updates
6.5 Ypsomed AG
6.5.1 Ypsomed AG Corporation Information
6.5.2 Ypsomed AG Description and Business Overview
6.5.3 Ypsomed AG Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ypsomed AG Insulin Syringes Product Portfolio
6.5.5 Ypsomed AG Recent Developments/Updates
6.6 Wockhardt Ltd
6.6.1 Wockhardt Ltd Corporation Information
6.6.2 Wockhardt Ltd Description and Business Overview
6.6.3 Wockhardt Ltd Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Wockhardt Ltd Insulin Syringes Product Portfolio
6.6.5 Wockhardt Ltd Recent Developments/Updates
6.7 Medtronic Plc
6.6.1 Medtronic Plc Corporation Information
6.6.2 Medtronic Plc Description and Business Overview
6.6.3 Medtronic Plc Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic Plc Insulin Syringes Product Portfolio
6.7.5 Medtronic Plc Recent Developments/Updates
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Corporation Information
6.8.2 Abbott Laboratories Description and Business Overview
6.8.3 Abbott Laboratories Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbott Laboratories Insulin Syringes Product Portfolio
6.8.5 Abbott Laboratories Recent Developments/Updates
6.9 Animas Corporation
6.9.1 Animas Corporation Corporation Information
6.9.2 Animas Corporation Description and Business Overview
6.9.3 Animas Corporation Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Animas Corporation Insulin Syringes Product Portfolio
6.9.5 Animas Corporation Recent Developments/Updates
6.10 F. Hoffmann-La Roche
6.10.1 F. Hoffmann-La Roche Corporation Information
6.10.2 F. Hoffmann-La Roche Description and Business Overview
6.10.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.10.4 F. Hoffmann-La Roche Insulin Syringes Product Portfolio
6.10.5 F. Hoffmann-La Roche Recent Developments/Updates
6.11 BD
6.11.1 BD Corporation Information
6.11.2 BD Insulin Syringes Description and Business Overview
6.11.3 BD Insulin Syringes Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BD Insulin Syringes Product Portfolio
6.11.5 BD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Syringes Industry Chain Analysis
7.2 Insulin Syringes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Syringes Production Mode & Process
7.4 Insulin Syringes Sales and Marketing
7.4.1 Insulin Syringes Sales Channels
7.4.2 Insulin Syringes Distributors
7.5 Insulin Syringes Customers
8 Insulin Syringes Market Dynamics
8.1 Insulin Syringes Industry Trends
8.2 Insulin Syringes Market Drivers
8.3 Insulin Syringes Market Challenges
8.4 Insulin Syringes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Insulin Syringes Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Insulin Syringes Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Insulin Syringes Market Competitive Situation by Manufacturers in 2022
Table 4. Global Insulin Syringes Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Insulin Syringes Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Insulin Syringes Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Insulin Syringes Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Insulin Syringes Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Insulin Syringes, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Insulin Syringes, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Syringes, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Syringes, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Syringes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Syringes as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Syringes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Insulin Syringes Sales by Region (2018-2023) & (K Units)
Table 18. Global Insulin Syringes Sales Market Share by Region (2018-2023)
Table 19. Global Insulin Syringes Sales by Region (2024-2029) & (K Units)
Table 20. Global Insulin Syringes Sales Market Share by Region (2024-2029)
Table 21. Global Insulin Syringes Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Insulin Syringes Revenue Market Share by Region (2018-2023)
Table 23. Global Insulin Syringes Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Insulin Syringes Revenue Market Share by Region (2024-2029)
Table 25. North America Insulin Syringes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Insulin Syringes Sales by Country (2018-2023) & (K Units)
Table 27. North America Insulin Syringes Sales by Country (2024-2029) & (K Units)
Table 28. North America Insulin Syringes Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Insulin Syringes Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Insulin Syringes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Insulin Syringes Sales by Country (2018-2023) & (K Units)
Table 32. Europe Insulin Syringes Sales by Country (2024-2029) & (K Units)
Table 33. Europe Insulin Syringes Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Insulin Syringes Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Insulin Syringes Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Insulin Syringes Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Insulin Syringes Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Insulin Syringes Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Insulin Syringes Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Insulin Syringes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Insulin Syringes Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Insulin Syringes Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Insulin Syringes Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Insulin Syringes Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Insulin Syringes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Insulin Syringes Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Insulin Syringes Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Insulin Syringes Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Insulin Syringes Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Insulin Syringes Sales (K Units) by Type (2018-2023)
Table 51. Global Insulin Syringes Sales (K Units) by Type (2024-2029)
Table 52. Global Insulin Syringes Sales Market Share by Type (2018-2023)
Table 53. Global Insulin Syringes Sales Market Share by Type (2024-2029)
Table 54. Global Insulin Syringes Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Insulin Syringes Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Insulin Syringes Revenue Market Share by Type (2018-2023)
Table 57. Global Insulin Syringes Revenue Market Share by Type (2024-2029)
Table 58. Global Insulin Syringes Price (USD/Unit) by Type (2018-2023)
Table 59. Global Insulin Syringes Price (USD/Unit) by Type (2024-2029)
Table 60. Global Insulin Syringes Sales (K Units) by Application (2018-2023)
Table 61. Global Insulin Syringes Sales (K Units) by Application (2024-2029)
Table 62. Global Insulin Syringes Sales Market Share by Application (2018-2023)
Table 63. Global Insulin Syringes Sales Market Share by Application (2024-2029)
Table 64. Global Insulin Syringes Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Insulin Syringes Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Insulin Syringes Revenue Market Share by Application (2018-2023)
Table 67. Global Insulin Syringes Revenue Market Share by Application (2024-2029)
Table 68. Global Insulin Syringes Price (USD/Unit) by Application (2018-2023)
Table 69. Global Insulin Syringes Price (USD/Unit) by Application (2024-2029)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Novo Nordisk Insulin Syringes Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Sanofi Insulin Syringes Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Business Overview
Table 82. Eli Lilly and Company Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly and Company Insulin Syringes Product
Table 84. Eli Lilly and Company Recent Developments/Updates
Table 85. Biocon Ltd Corporation Information
Table 86. Biocon Ltd Description and Business Overview
Table 87. Biocon Ltd Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Biocon Ltd Insulin Syringes Product
Table 89. Biocon Ltd Recent Developments/Updates
Table 90. Ypsomed AG Corporation Information
Table 91. Ypsomed AG Description and Business Overview
Table 92. Ypsomed AG Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Ypsomed AG Insulin Syringes Product
Table 94. Ypsomed AG Recent Developments/Updates
Table 95. Wockhardt Ltd Corporation Information
Table 96. Wockhardt Ltd Description and Business Overview
Table 97. Wockhardt Ltd Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Wockhardt Ltd Insulin Syringes Product
Table 99. Wockhardt Ltd Recent Developments/Updates
Table 100. Medtronic Plc Corporation Information
Table 101. Medtronic Plc Description and Business Overview
Table 102. Medtronic Plc Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Medtronic Plc Insulin Syringes Product
Table 104. Medtronic Plc Recent Developments/Updates
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Abbott Laboratories Insulin Syringes Product
Table 109. Abbott Laboratories Recent Developments/Updates
Table 110. Animas Corporation Corporation Information
Table 111. Animas Corporation Description and Business Overview
Table 112. Animas Corporation Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Animas Corporation Insulin Syringes Product
Table 114. Animas Corporation Recent Developments/Updates
Table 115. F. Hoffmann-La Roche Corporation Information
Table 116. F. Hoffmann-La Roche Description and Business Overview
Table 117. F. Hoffmann-La Roche Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. F. Hoffmann-La Roche Insulin Syringes Product
Table 119. F. Hoffmann-La Roche Recent Developments/Updates
Table 120. BD Corporation Information
Table 121. BD Description and Business Overview
Table 122. BD Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. BD Insulin Syringes Product
Table 124. BD Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Insulin Syringes Distributors List
Table 128. Insulin Syringes Customers List
Table 129. Insulin Syringes Market Trends
Table 130. Insulin Syringes Market Drivers
Table 131. Insulin Syringes Market Challenges
Table 132. Insulin Syringes Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Syringes
Figure 2. Global Insulin Syringes Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Insulin Syringes Market Share by Type in 2022 & 2029
Figure 4. 3/10 CC Syringe Product Picture
Figure 5. 1/2 CC Syringe Product Picture
Figure 6. 1 CC Syringe Product Picture
Figure 7. Others Product Picture
Figure 8. Global Insulin Syringes Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Insulin Syringes Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Homecare
Figure 12. Others
Figure 13. Global Insulin Syringes Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Insulin Syringes Market Size (2018-2029) & (US$ Million)
Figure 15. Global Insulin Syringes Sales (2018-2029) & (K Units)
Figure 16. Global Insulin Syringes Average Price (USD/Unit) & (2018-2029)
Figure 17. Insulin Syringes Report Years Considered
Figure 18. Insulin Syringes Sales Share by Manufacturers in 2022
Figure 19. Global Insulin Syringes Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Insulin Syringes Players: Market Share by Revenue in 2022
Figure 21. Insulin Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Insulin Syringes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Insulin Syringes Sales Market Share by Country (2018-2029)
Figure 24. North America Insulin Syringes Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Insulin Syringes Sales Market Share by Country (2018-2029)
Figure 28. Europe Insulin Syringes Revenue Market Share by Country (2018-2029)
Figure 29. Germany Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Insulin Syringes Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Insulin Syringes Revenue Market Share by Region (2018-2029)
Figure 36. China Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Insulin Syringes Sales Market Share by Country (2018-2029)
Figure 47. Latin America Insulin Syringes Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Insulin Syringes Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Insulin Syringes Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E Insulin Syringes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Insulin Syringes by Type (2018-2029)
Figure 57. Global Revenue Market Share of Insulin Syringes by Type (2018-2029)
Figure 58. Global Insulin Syringes Price (USD/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Insulin Syringes by Application (2018-2029)
Figure 60. Global Revenue Market Share of Insulin Syringes by Application (2018-2029)
Figure 61. Global Insulin Syringes Price (USD/Unit) by Application (2018-2029)
Figure 62. Insulin Syringes Value Chain
Figure 63. Insulin Syringes Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Immunoglobulins: Global Market Outlook
    Published: 30-Mar-2023        Price: US 3500 Onwards        Pages: 64
    Report Scope: The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market. In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific ......
  • Global Liquid Biopsy Products Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 30-Mar-2023        Price: US 3260 Onwards        Pages: 97
    The Liquid Biopsy Products market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Liquid Biopsy Products industry, and breaks down according to the type, application, and consumption area of Liquid Biopsy Products. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and......
  • Global Sleeping Aids Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 30-Mar-2023        Price: US 3260 Onwards        Pages: 95
    The Sleeping Aids market revenue was 67413.19 Million USD in 2022, and will reach 97992.26 Million USD in 2028, with a CAGR of 6.43% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Sleeping Aids industry, and breaks down according to the type, application, and consumption area of Sleeping Aids. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes th......
  • Global Liver Detox Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 30-Mar-2023        Price: US 3260 Onwards        Pages: 103
    The liver is an important detoxification organ, and liver detoxification is a process in which various toxins are converted into non-toxic or low-toxic substances after a series of chemical reactions in the liver. The Liver Detox market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Liver Detox industry, and breaks down ac......
  • Global Pharmaceutical Grade Sodium Chloride Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 30-Mar-2023        Price: US 3260 Onwards        Pages: 118
    The Pharmaceutical Grade Sodium Chloride market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharmaceutical Grade Sodium Chloride industry, and breaks down according to the type, application, and consumption area of Pharmaceutical Grade Sodium Chloride. The report also introduces players in the industry from the perspective of ......
  • Global Microbial Fermentation APIs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 28-Mar-2023        Price: US 3260 Onwards        Pages: 106
    Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamins, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply). The Mi......
  • Global Hospital Pharmaceuticals Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 28-Mar-2023        Price: US 3260 Onwards        Pages: 119
    The Hospital Pharmaceuticals market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Hospital Pharmaceuticals industry, and breaks down according to the type, application, and consumption area of Hospital Pharmaceuticals. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Blood Serum Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 28-Mar-2023        Price: US 3260 Onwards        Pages: 121
    The Blood Serum market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Blood Serum industry, and breaks down according to the type, application, and consumption area of Blood Serum. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
  • Global Bone Morphogenetic Protein (Bmp) 2 Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 28-Mar-2023        Price: US 3260 Onwards        Pages: 110
    Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance. The Bone Morphogenetic Protein (Bmp) 2 market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elabo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs